Certification Rate
100%
Very high DOL cert
2026 data Public-data reference Official source
Zydus Pharmaceuticals (USA), Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 11
- DOL-certified
- 100%
- Median offered wage
- $125,498
PENNINGTON, NJ NAICS: 325412
How many H-1B LCA filings list Zydus Pharmaceuticals (USA), Inc.?
U.S. Department of Labor's OFLC discloses 11 Labor Condition Application filings naming Zydus Pharmaceuticals (USA), Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Zydus Pharmaceuticals (USA), Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 34 H-1B petitions naming Zydus Pharmaceuticals (USA), Inc. through FY2024, and approved nearly every one of them: 100% approved (34 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Zydus Pharmaceuticals (USA), Inc. is listed in 11 DOL LCA filings, more filings than 86% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $125,498. This is not a USCIS approval, hiring, or sponsorship ranking.
- 11
- DOL LCA filings, FY2023–FY2026
- 100%
- DOL-certified
- $125,498
- median offered wage
- Top 14%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in PENNINGTON, NJ.
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Zydus Pharmaceuticals (USA), Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
11 17820th of 122824 higher than 105,004 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Zydus Pharmaceuticals, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $70,100–$207,675 .
Title concentration
- Supply Chain Analyst 1 · 9.1% · $70,100
- Senior Manager, Regulatory Affairs & Supply Chain 1 · 9.1% · $158,250
- Senior Manager, Regulatory Affairs 1 · 9.1% · $158,250
- Senior Analyst, Regulatory Affairs 1 · 9.1% · $97,000
- Senior Analyst, Medicaid & Government Pricing 1 · 9.1% · $88,200
Worksite counties
- MERCER, NJ 10 · 100%
Above-prevailing wage posture
On 11 LCAs with comparable offered vs prevailing wages, Zydus Pharmaceuticals (USA), Inc. averages about 19% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (54.5% of LCA filings).
Mercer, NJ worksite concentration
Only 11 LCAs on file for Zydus Pharmaceuticals, Inc., and 90.9% land in MERCER, NJ. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Avg. Salary
$125,498
Above portal avg
Total Workers
11
Small worker count
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Zydus Pharmaceuticals (USA), Inc.
Minimum
$70,100
Maximum
$207,675
Average Salary
$125,498
Wage vs. DOL Minimum
+19%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Qualified (Level II)
54.5% of LCA filings
Full-Time Positions
100%
Primary Worksite County
MERCER, NJ
90.9% of LCA filings
Top Occupations
Most frequently listed job titles at Zydus Pharmaceuticals (USA), Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Supply Chain Analyst | 1 | $70,100 |
| Senior Manager, Regulatory Affairs & Supply Chain | 1 | $158,250 |
| Senior Manager, Regulatory Affairs | 1 | $158,250 |
| Senior Analyst, Regulatory Affairs | 1 | $97,000 |
| Senior Analyst, Medicaid & Government Pricing | 1 | $88,200 |
| Senior Analyst Regulatory Affairs | 1 | $87,000 |
| Manager, Regulatory Affairs | 1 | $112,000 |
| Manager, Accounts Payable | 1 | $137,000 |
| IT Business Analyst | 1 | $150,000 |
| Drug Safety Associate | 1 | $115,000 |
| Director - IT | 1 | $207,675 |
Nationwide peers near Zydus Pharmaceuticals, Inc.'s 11-LCA band
Cross-state DOL neighbors for Zydus Pharmaceuticals (USA), Inc. - LCA filing-count and offered-wage axes, outside NJ.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (11 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($125,498 here).
Frequently Asked Questions
How many H-1B LCA filings list Zydus Pharmaceuticals (USA), Inc.?
Zydus Pharmaceuticals (USA), Inc. is listed in 11 DOL Labor Condition Application filings covering 11 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
How does Zydus Pharmaceuticals (USA), Inc.'s LCA filing volume compare to other employer filers?
Among 122,824 employer filers in the DOL disclosure extract, Zydus Pharmaceuticals (USA), Inc. ranks #16713 by total LCA filing count (11 filings). 105,004 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
What is the H-1B DOL certification rate for Zydus Pharmaceuticals (USA), Inc.?
Zydus Pharmaceuticals (USA), Inc. has a 100% DOL certification rate, with 11 out of 11 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
What offered wage is listed in LCAs for Zydus Pharmaceuticals (USA), Inc.?
The average offered wage listed in Zydus Pharmaceuticals (USA), Inc.'s LCAs is $125,498. Listed wages range from $70,100 to $207,675 and are not verified actual compensation.
What are the most common H-1B job titles at Zydus Pharmaceuticals (USA), Inc.?
The top job titles in Zydus Pharmaceuticals (USA), Inc.'s LCA filing records include Supply Chain Analyst, Senior Manager, Regulatory Affairs & Supply Chain, Senior Manager, Regulatory Affairs. The most common listed title is Supply Chain Analyst with 1 LCA filings at an average listed offered wage of $70,100. This does not establish actual job openings, hiring, or approved petitions.
Where is Zydus Pharmaceuticals (USA), Inc. located?
Zydus Pharmaceuticals (USA), Inc. is headquartered in PENNINGTON, NJ.
Is Zydus Pharmaceuticals (USA), Inc. H-1B dependent?
No, Zydus Pharmaceuticals (USA), Inc. is not classified as H-1B dependent.
How have Zydus Pharmaceuticals (USA), Inc.'s listed LCA filings changed over time?
Zydus Pharmaceuticals (USA), Inc. is listed in 4 LCA filings in FY2023 and 1 in FY2026. The average listed offered wage increased from $148,569 to $150,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
Read with Zydus Pharmaceuticals, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
12th Wonder LLC · MICRO-BOOK
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs Zydus Pharmaceuticals, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
1upHealth, Inc. · MICRO-BOOK
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs Zydus Pharmaceuticals, Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
2Go Products, LLC. · MICRO-BOOK
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs Zydus Pharmaceuticals, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
4 S.T.E.L. Engineering, Inc. · MICRO-BOOK
ABS(total_petitions) peer at 11 LCAs (Δ 0 heavier vs Zydus Pharmaceuticals, Inc.); CERT-SOLID · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
Ernst & Young US LLP · LARGEST-distance pole
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Zydus Pharmaceuticals, Inc.'s MICRO-BOOK.
NJ worksite board · MICRO-BOOK
Open the NJ state board after the ABS peers. Zydus Pharmaceuticals, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Salary calculator · WAGE-PREMIUM
Zydus Pharmaceuticals, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Zydus Pharmaceuticals (USA), Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Zydus Pharmaceuticals (USA), Inc. filed 11 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 86% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in NJ rank on LCA filing volume this vintage. NJ filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.